mRNA |
Gefitinib |
FIMM |
pan-cancer |
AAC |
0.015 |
0.9 |
mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
0.003 |
0.9 |
mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
mRNA |
GDC-0941 |
GDSC1000 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
-0.0025 |
0.9 |